Parallel Advisors’s Acceleron Pharma XLRN Stock Holding History

Parallel Advisors’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-36	Closed	-$6K	–	3437
2021 Q3	$6K	Hold	36	–	–	﹤0.01%	2323
2021 Q2	$5K	Sell	36 -18	-33%	-$2.27K	﹤0.01%	2329
2021 Q1	$7K	Buy	54 +45	+500%	+$5.81K	﹤0.01%	2094
2020 Q4	$1K	Buy	+9	New	+$1.05K	﹤0.01%	2537

Parallel Advisors's XLRN Position: Q4 2021 in Review

Parallel Advisors sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 36 shares — an estimated $6K sold.

Parallel Advisors first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $7K in Q1 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Parallel Advisors reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Parallel Advisors sold 36 Acceleron Pharma shares in Q4 2021, an estimated $6K.
Parallel Advisors first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
Parallel Advisors's Acceleron Pharma position peaked at $7K in Q1 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.